Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

about

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Item

http://www.wikidata.org/entity/Q49647319

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@en

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@nl

type

Item

label

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@en

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@nl

prefLabel

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@en

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

@nl

P1476

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants

@en

P2093

Elaine M Hylek

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Dabigatran versus warfarin in patients with atrial fibrillation

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Dabigatran versus warfarin in patients with mechanical heart valves

P31

scholarly article

P356

10.1161/JAHA.117.007338

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Konstantinos N. Aronis

P577

2018-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29374049

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation

P932

5850242

http://www.w3.org/2001/XMLSchema#string